… We evaluated the efficacy of treatment in 85 patients with RA for whom leukocytapheresis
(LCAP) was initiated at our hospital between 2006 and 2015. All patients continued drug …

CiNii 博士論文 - Safety and Efficacy of the Leukocytapheresis procedure in eighty-five
patients with Rheumatoid arthritis. … Safety and Efficacy of the Leukocytapheresis …

… The current study intended to evaluate the efficacy and safety of leukocytopheresis (LCAP)
for … Safety and efficacy of the leukocytapheresis procedure in eighty-five patients with …

… Every DMARD therapy failed due to primary lack of efficacy, secondary loss of efficacy, or …
After five LCAP procedures at one-week intervals, the patient achieved low disease activity …

… Before and after LCAP, we evaluated the effect of LCAP therapy. … LCAP therapy may be
useful and safe for patients with RA resistant to conventional medication. Patients who show …

… Leukocytapheresis(LCAP) is an alternative to thoracic duct drainage and LCAP using a
centrifuge method … Clinical trials revealed that LCAP is a safe and effective therapy for patients …

… -nuclear antibodies and rheumatoid factor with stabilization of … of rheumatoid arthritis,
leukocytapheresis methods are also … A multitarget method for the treatment of rheumatoid arthritis. …

… leukemia, tumors, rheumatoid arthritis and other diseases and … switch off to ensure the safety
of apheresis procedures[22]. … above that selective leukocytapheresis significantly reduces …

… diseases such as IBD, rheumatoid arthritis, and others [1–5]. … Eighty-five percent of patients
with active UC and all patients … in the local inflammatory process. The expected recovery of …

… Eighty-five (53.5%) of 159 patients with active UC were … , and Janus kinase inhibitor with
leukocytapheresis (LCAP), … Although PR3-ANCA was measured using the same CLEIA method …